Atrial fibrillation: insights from clinical trials and novel treatment options

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Internal Medicine

• Publication date

  2007-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2796.2007.01885.xPMID 18028181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The surgical treatment of atrial fibrillation.

  2009cited by this paper
• Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation.

  2007cited by this paper
• Model-Dependent Effects of the Gap Junction Conduction–Enhancing Antiarrhythmic Peptide Rotigaptide (ZP123) on Experimental Atrial Fibrillation in Dogs

  2007cited by this paper
• The association of human connexin 40 genetic polymorphisms with atrial fibrillation.

  2007cited by this paper
• Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.

  2007cited by this paper
• Kir3-Based Inward Rectifier Potassium Current: Potential Role in Atrial Tachycardia Remodeling Effects on Atrial Repolarization and Arrhythmias

  2006cited by this paper
• Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.

  2006cited by this paper
• Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies.

  2006cited by this paper
• Atrial fibrillation: Catheter ablation

  2006cited by this paper
• Effects of the Gap Junction Modifier Rotigaptide (ZP123) on Atrial Conduction and Vulnerability to Atrial Fibrillation

  2006cited by this paper
• Circumferential pulmonary-vein ablation for chronic atrial fibrillation.

  2006cited by this paper
• Direct thrombin inhibitors – a survey of recent developments

  2006cited by this paper
• Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart Failure

  2006cited by this paper
• ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC

  2006cited by this paper
• Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.

  2006cited by this paper
• Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.

  2006cited by this paper
• Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion.

  2006cited by this paper
• Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation.

  2006cited by this paper
• Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study).

  2006cited by this paper
• Totally endoscopic ablation of lone atrial fibrillation: initial clinical experience.

  2006cited by this paper
• Guidelines for the Management of Patients With Atrial Fibrillation

  2006cited by this paper
• Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study

  2006cited by this paper
• ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ

  2006cited by this paper
• Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial Fibrillation: A Randomized Comparison Between 2 Current Ablation Strategies

  2005cited by this paper
• Amiodarone versus sotalol for atrial fibrillation.

  2005cited by this paper
• Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.

  2005cited by this paper
• Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction.

  2005cited by this paper
• Direct thrombin inhibitors.

  2005cited by this paper
• Linear Cryoablation of the Left Atrium Versus Pulmonary Vein Cryoisolation in Patients With Permanent Atrial Fibrillation and Valvular Heart Disease: Correlation of Electroanatomic Mapping and Long-Term Clinical Results

  2005cited by this paper
• Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation

  2005cited by this paper
• Surgical treatment of atrial fibrillation: predictors of late recurrence.

  2005cited by this paper
• The Mechanism of Atrial Antiarrhythmic Action of RSD1235

  2005cited by this paper
• The G Protein–Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation

  2005cited by this paper
• Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

  2005cited by this paper
• Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.

  2005cited by this paper
• Left Ventricular‐Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study)

  2005cited by this paper
• Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies

  2005cited by this paper
• Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

  2005cited by this paper
• Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

  2005cited by this paper
• Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

  2005cited by this paper
• Effect of C-reactive protein reduction on paroxysmal atrial fibrillation.

  2005cited by this paper
• Characterization of a hyperpolarization‐activated time‐dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium

  2004cited by this paper
• Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK

  2004cited by this paper
• Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.

  2004cited by this paper
• Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.

  2004cited by this paper
• Catheter cryoablation of cardiac arrhythmias

  2004cited by this paper
• Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs

  2004cited by this paper
• Relationship Between Connexins and Atrial Activation During Human Atrial Fibrillation

  2004cited by this paper
• Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels

  2004cited by this paper
• Cox/Maze III operation versus radiofrequency ablation for the surgical treatment of atrial fibrillation: a comparative study.

  2004cited by this paper
• Catheter ablation for atrial fibrillation in congestive heart failure.

  2004cited by this paper
• Electrical Remodeling and Chronic Atrial Fibrillation

  2004cited by this paper
• Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion.

  2004cited by this paper
• Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.

  2004cited by this paper
• Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1

  2004cited by this paper
• Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model.

  2004cited by this paper
• Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.

  2004cited by this paper
• Advances in surgical treatment of atrial fibrillation.

  2004cited by this paper
• Electrophysiologic and electroanatomic changes in the human atrium associated with age.

  2004cited by this paper
• A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.

  2004cited by this paper
• Role of IKur in Controlling Action Potential Shape and Contractility in the Human Atrium: Influence of Chronic Atrial Fibrillation

  2004cited by this paper
• Atrio-Esophageal Fistula as a Complication of Percutaneous Transcatheter Ablation of Atrial Fibrillation

  2004cited by this paper
• The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.

  2004cited by this paper
• Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.

  2004cited by this paper
• The use of knockout mouse technology to achieve tissue selective expression of angiotensin converting enzyme.

  2004cited by this paper
• “Early” Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat

  2004cited by this paper
• Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways

  2003cited by this paper
• Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography

  2003cited by this paper
• Catheter Ablation for Paroxysmal Atrial Fibrillation: Segmental Pulmonary Vein Ostial Ablation Versus Left Atrial Ablation

  2003cited by this paper
• Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.

  2003cited by this paper
• Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999: Implications for Primary Prevention

  2003cited by this paper
• Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm.

  2003cited by this paper
• Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.

  2003cited by this paper
• Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation.

  2003cited by this paper
• Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease.

  2003cited by this paper
• Combined Antiplatelet Therapy in Atrial Fibrillation:

  2003cited by this paper
• Combined antiplatelet therapy in atrial fibrillation: review of the literature and future avenues.

  2003cited by this paper
• Electrical Remodeling of the Atria in Congestive Heart Failure: Electrophysiological and Electroanatomic Mapping in Humans

  2003cited by this paper
• A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation

  2003cited by this paper
• Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

  2003cited by this paper
• Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.

  2003cited by this paper
• Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.

  2003cited by this paper
• Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials

  2003cited by this paper
• Effects of Antiarrhythmic Drugs on Fibrillation in the Remodeled Atrium: Insights Into the Mechanism of the Superior Efficacy of Amiodarone

  2003cited by this paper
• Specific linear left atrial lesions in atrial fibrillation: intraoperative radiofrequency ablation using minimally invasive surgical techniques.

  2002cited by this paper
• Left atrial versus bi-atrial Maze operation using intraoperatively cooled-tip radiofrequency ablation in patients undergoing open-heart surgery: safety and efficacy.

  2002cited by this paper
• Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.

  2002cited by this paper
• A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

  2002cited by this paper
• Structural correlate of atrial fibrillation in human patients.

  2002cited by this paper
• No effects of Na+/H+ exchange-inhibitors on atrial electrical remodeling and atrial fibrillation in the goat

  2002cited by this paper
• Pirfenidone Treatment Decreases Transforming Growth Factor‐β1 and Matrix Proteins and Ameliorates Fibrosis in Chronic Cyclosporine Nephrotoxicity

  2002cited by this paper
• Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation.

  2002cited by this paper
• A comparison of rate control and rhythm control in patients with atrial fibrillation.

  2002cited by this paper
• Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study

  2002cited by this paper
• Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in Europe: Data From a Multicenter Multinational Hospital–Based Registry (The European Community Stroke Project)

  2001cited by this paper
• Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter.

  2001cited by this paper
• Inhibition by a novel anti-arrhythmic agent, NIP-142, of cloned human cardiac K+ channel Kv1.5 current.

  2001cited by this paper
• Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

  2001cited by this paper
• Ascorbate Attenuates Atrial Pacing-Induced Peroxynitrite Formation and Electrical Remodeling and Decreases the Incidence of Postoperative Atrial Fibrillation

  2001cited by this paper
• Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs.

  2001cited by this paper

• Enhancing precision in window to the brain modeling: Methodology and implementation of hybrid digital twins

  2025cites this paper
• Puerarin Decreases Collagen Secretion in AngII-Induced Atrial Fibroblasts Through Inhibiting Autophagy Via the JNK-Akt-mTOR Signaling Pathway.

  2019cites this paper
• Identification and characterization of circular RNAs in rapid atrial pacing dog atrial tissue.

  2018cites this paper
• Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review

  2018cites this paper
• Near-Infrared Spectroscopy-Based Microcirculatory Assessment in Acute Atrial Fibrillation

  2015cites this paper
• Effect of angiotensin II on STAT3 mediated atrial structural remodeling.

  2014cites this paper
• Modeling of Radiofrequency Ablation Lesions for Image-Guided Arrhythmia Therapy: A Preliminary ex vivo Demonstration

  2012cites this paper
• Atrial Fibrillation Induces Myocardial Fibrosis Through Angiotensin II Type 1 Receptor–Specific Arkadia-Mediated Downregulation of Smad7

  2011cites this paper
• Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients aged >or=65 years. The FAPRES trial.

  2010cites this paper
• Protocolo de tratamiento de la fibrilación auricular

  2010cites this paper
• Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES.

  2010cites this paper
• A combined surface and volumetric approach for registration of patient specific models into left atrial cardiac ablation procedures

  2009cites this paper
• Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.

  2009cites this paper
• An event-driven distributed processing architecture for image-guided cardiac ablation therapy

  2009cites this paper
• The adenosine A1 receptor and its ligands.

  2009cites this paper
• Narrow complex (supraventricular) tachycardias

  2009cites this paper
• Combination Pharmacological Cardioversion of Permanent Atrial Fibrillation in Post-prosthetic Mitral Valve Replacement Outpatients: A Novel Approach for the Treatment of Atrial Fibrillation

  2008cites this paper
• Angiotensin blockade and general anesthesia: so little known, so far to go.

  2008cites this paper
• The place of hybrid therapies with drugs to supplement nonpharmacological therapies in atrial fibrillation.

  2008cites this paper
• Update on cardiac arrhythmias in the ICU

  2008cites this paper